Related Experiment Video
Updated: Jan 8, 2026

Molecular Modulation by Lentivirus-Delivered Specific shRNAs in Endoplasmic Reticulum Stressed Neurons
Published on: April 24, 2021
Endoplasmic reticulum stress-mediated programmed cell death in the tumor microenvironment.
Hongyu Chai1, Qian Hu1, Shun Yao1
1Department of Gastroenterology, Digestive Disease Hospital, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, PR China.
Endoplasmic reticulum stress (ERS) regulates cell death pathways in tumors via the unfolded protein response (UPR). Targeting this "ERS-Death Axis" shows therapeutic promise but faces challenges like tumor heterogeneity.
Area of Science:
- Oncology
- Cell Biology
- Molecular Biology
Background:
- Endoplasmic reticulum stress (ERS) is a cellular state arising from the accumulation of unfolded proteins within the endoplasmic reticulum.
- The unfolded protein response (UPR) comprises three key signaling pathways: PERK, IRE1α, and ATF6, which regulate cellular adaptation or death.
- ERS plays a critical role in the tumor microenvironment (TME), influencing cancer cell survival and death.
Purpose of the Study:
- To elucidate the molecular mechanisms of the "ERS-Death Axis" in cancer.
- To explore the interconnectedness of ERS-mediated cell death pathways (apoptosis, autophagy, pyroptosis, ferroptosis).
- To review therapeutic strategies targeting the ERS-Death Axis and identify clinical translation challenges.
Main Methods:
- Review of existing literature on ERS, UPR, and cancer cell death.
- Analysis of molecular pathways involved in ERS-mediated cell fate decisions.
- Examination of preclinical and clinical data on therapeutic interventions.
Main Results:
- The ERS-Death Axis integrates apoptosis, autophagy, pyroptosis, and ferroptosis through specific molecular mediators like CHOP, NLRP3 inflammasome, and ATF4-CHAC1.
- Oxidative stress exacerbates the functions of this network.
- Significant tumor-specific heterogeneity exists within the ERS-Death Axis.
- Therapeutic strategies including UPR modulation, natural compounds, combination therapies, and nanodelivery show potential.
Conclusions:
- The ERS-Death Axis is a critical regulator of cell fate in the TME, offering a promising target for cancer therapy.
- Overcoming challenges like tumor heterogeneity and drug delivery is essential for clinical translation.
- Further research into tumor-specific mechanisms will optimize combination regimens and advance precision oncology.
More Related Videos
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
06:12Author Spotlight: THP-1 Macrophage Response to LPS/ATP — Unveiling the Pyroptosis, Apoptosis, and Necroptosis Spectrum
Published on: May 3, 2024
Related Concept Videos
The Tumor Microenvironment
Regulation of the Unfolded Protein Response
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...